Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.47 |
| ▸ | MAPT | P10636 | 6/20 | 0.47 |
| ▸ | HPGD | P15428 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | NPC1 | O15118 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25796473 | 1.00 | ALDH1A1 (0.47) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL27053494 | 0.95 | ABCB1 (0.47) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL25755273 | 0.84 | ABCB1 (0.50) | ALDH1A1MAPTRAB9ANPC1ABCB1 | |
| SCHEMBL24278598 | 0.84 | ABCB1 (0.50) | ALDH1A1MAPTRAB9ANPC1ABCB1 | |
| SCHEMBL27105309 | 0.84 | ABCB1 (0.50) | ALDH1A1MAPTRAB9ANPC1ABCB1 | |
| SCHEMBL25796830 | 0.83 | CHRNA7 (0.49) | GAATSHRKMT2AMEN1 | |
| SCHEMBL25755225 | 0.83 | CHRNA7 (0.49) | GAATSHRKMT2AMEN1 | |
| SCHEMBL24278683 | 0.83 | CHRNA7 (0.49) | GAATSHRKMT2AMEN1 | |
| SCHEMBL25796848 | 0.83 | CHRNA7 (0.49) | GAATSHRKMT2AMEN1 | |
| SCHEMBL27053452 | 0.83 | CHRNA7 (0.49) | GAATSHRKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025838-A1 | ESTER COMPOUND | MITSUI CHEMICALS, INC. (JP) | 2024-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025838-A1 | ESTER COMPOUND | NR1H3, CYP4A11, H1-4 | ALDH1A1 650/4885MAPT 4458/4885HPGD 3003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.